author-photo

Roberto Sorio

National Institutes of Health

174

Papers

4781

Citations

Citation Trend

Filter By

Papers (121) Sort By

Journal Conference Others

800P Tailoring adjuvant treatments in high-risk early stage endometrial cancer: Clinical outcomes of sequential chemoradiation in a real-word scenario

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future Perspectives.

2021 Cancers
Show All
- Source
- Cite
- Save
Citations (0)
Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database.

2021 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (1)
A European, observational, prospective trial of trabectedin plus pegylated liposomal doxorubicin in patients with platinum-sensitive ovarian cancer.

2020 Oncologist
Show All
- Source
- Cite
- Save
Citations (3)
Human epidermal growth factor receptor-2 (HER2) is a potential therapeutic target in extramammary Paget's disease of the vulva.

2020 International Journal of Gynecological Cancer
Show All
- Source
- Cite
- Save
Citations (4)
EP795 Searching for the best maintenance therapy in platinum-sensitive recurrent ovarian cancer: bevacizumab or PARP-inhibitors? A network meta-analysis

2019
Show All
- Source
- Cite
- Save
Citations (0)
Prognostic role of chemotherapy-induced neutropenia in first-line treatment of advanced ovarian cancer. A pooled analysis of MITO2 and MITO7 trials

2019 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (5)
1015PAdvanced ovarian cancer: Is residual disease after debulking surgery affected by genetics factors involved in angiogenesis and immunity pathways?

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clonal Evolution of TP53 c.375+1G>A Mutation in Pre- and Post- Neo-Adjuvant Chemotherapy (NACT) Tumor Samples in High-Grade Serous Ovarian Cancer (HGSOC)

2019 Cells
Show All
- Source
- Cite
- Save
Citations (3)
1022PTP53 hotspot mutations as immunoreactive neoantigens define a signature with differential survival outcomes in advanced ovarian cancer

2019 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)